Understanding the Prozone Effect in Immunoassays: False Negatives

Hook effect susceptibility varies by assay. Troglobulin cases show values above 300 ng/mL triggering dilution protocols. A case showed 364 ng/mL dropping to 222,000 ng/mL after dilution. Literature reports are rare, mostly involving HCG and tumor markers. A notable case showed troglobulin of zero rising to 65,000 ng/mL after dilution. The mechanism involves insufficient reagents for antibody binding when analyte concentration exceeds assay capacity.

The VDRL (Venereal Disease Research Laboratory) test is a non-specific serological test for syphilis screening that detects non-specific antibodies produced during infection through a flocculation reaction between patient antibodies, cardiolipin, and cholesterol microparticles. A critical diagnostic pitfall is the prozone effect, where high antibody concentrations prevent flocculation, causing false negative results; therefore, laboratories must always perform both undiluted and diluted (at least 1:4) samples to ensure accurate diagnosis.

This section addresses the relationship between prolactinoma size and prolactin levels. Microprolactinomas (<1 cm) typically have prolactin <500 ng/mL, while macroprolactinomas (>1 cm) usually exceed 500 ng/mL. However, the Hook effect (prozone phenomenon) can cause falsely low prolactin measurements when levels are extremely high (800-1000 ng/mL), interfering with assay detection. When encountering a large adenoma with unexpectedly low prolactin, laboratories should perform dilution studies (1:100) to reveal true values. This has critical clinical implications for treatment decisions.

Prolactin is a hormone produced by lactotrope cells in the anterior pituitary gland that stimulates milk secretion and breast development after childbirth, maintains lactation, aids in vitamin D, calcium, and carbohydrate metabolism, and supports testosterone production in men; the prolactin test is clinically significant for diagnosing pituitary tumors, infertility in women, erectile dysfunction and low sex drive in men, and conditions like galactorrhea and amenorrhea, with normal ranges being less than 20 ng/mL in men, less than 25 ng/mL in non-pregnant women, and 20-400 ng/mL in pregnant women, while elevated levels may indicate hypothalamus/pituitary tumors, pregnancy, breastfeeding, or hypothyroidism, and decreased levels can result from Sheehan's syndrome, head injury, or infections like tuberculosis.

VDRL is a quantitative test with titers ranging from 1:1 to 1:128 or higher. Higher titers indicate greater bacterial load and more active disease. The prozone effect occurs when bacterial titers are so high that they interfere with test detection, causing false negative results. This phenomenon is less common in reference laboratories but remains a consideration in clinical practice.

The Fuji Dri-Chem NX600V analyzer features an automatic dilution function that enables accurate testing of samples with excessively high values by automatically calculating and performing dilution, mixing the sample with dilution reagent, and multiplying the result by the dilution factor, thereby reducing human error and improving testing efficiency.

The EM 200 is a compact, fully automated random access discrete clinical chemistry analyzer designed for growing and mid-size laboratories, offering a throughput of 200 photometric tests per hour (or 400 tests/hr with ISE option) with features including a 39-position sample carousel, 50-position reagent carousel with onboard cooling, advanced robotic pipetting with vertical obstruction detection, eight-stage washing system, and integrated software with QC validation and auto-dilution capabilities for accurate and efficient routine chemistry, electrolytes, and immunoturbidimetry testing.

This workflow demonstrates the complete process for performing auto dilution calibrations using a single known standard. The procedure involves selecting Auto Dilution instead of Normal calibration mode, choosing the appropriate test type, and naming the calibration file. Unlike normal calibration, users enter the known standard concentration and desired diluted concentrations rather than multiple standard points. The machine automatically generates the necessary dilutions. After inserting the calibration into the sample table and reconnecting the machine, the calibration is executed by selecting Start. Results are automatically averaged with outliers excluded, and a linear calibration curve confirms successful execution before proceeding to sample analysis.

Sample dilution is essential when concentrations exceed instrument measurement ranges. Laboratories determine appropriate dilution factors based on expected concentrations, typically using normal saline or other suitable diluents. The dilution factor indicates how many times the sample has been diluted. For example, a 1:2 dilution means doubling the sample volume with equal diluent. When concentrations exceed instrument limits, analysts must perform serial dilutions and multiply final results by the dilution factor to obtain accurate original concentrations. Some modern analyzers include automatic dilution capabilities that detect out-of-range samples and perform serial dilutions automatically, while others require manual intervention.

An automated clinical chemistry analyzer is a laboratory device that measures concentrations or activities of biologically important substances (analytes) in body fluids such as blood, plasma, serum, urine, and cerebrospinal fluid. The analyzer operates on two main measurement principles: photometry (light absorption measurement) and potentiometry (electrochemical potential measurement). The workflow involves a pre-analytic phase where venous blood is drawn, allowed to clot, centrifuged to separate serum, and prepared for analysis; followed by an analytic phase with system checks, calibration using reference materials, quality control verification, and patient sample analysis. These analyzers are classified by automation level (stand-alone or modular for total laboratory automation), load size (ranging from small to very large capacity), and reagent type (wet liquid or dry reagents). Major manufacturers include Beckman Coulter, Roche, Siemens, and Medica, with common analytes including ions, molecules, enzymes, proteins, lipids, and metabolic markers used in diagnostic panels for assessing organ and system conditions.

This comprehensive section contrasts two fundamental immunoassay approaches. Competitive assays detect small molecules (<1 kDa) through displacement mechanisms where a weak binder competes with the target for binding sites. In contrast, sandwich assays detect large molecules (>1 kDa) including proteins, bacteria, and cells by capturing them between two distinct bioreceptors. The dual-receptor requirement ensures specificity and reduces false positives. Each format has unique optimization requirements: competitive assays need lower antibody concentrations while sandwich assays require high-density capture receptors (1 mg/mL) to prevent hook effects at high target concentrations.

In sandwich assays, analytes get sandwiched between biotinylated antibodies (bottom) and labeled antibodies (top), anchored to streptavidin-coated microparticles. High-dose biotin displaces biotinylated antibodies, washing them away and reducing light emission proportionally to analyte concentration. In competitive assays, the analyte competes with a labeled version for binding to biotinylated antibodies. High-dose biotin displaces biotinylated antibodies, reducing binding sites for both analyte and label. This causes false increases in measured analyte concentration regardless of actual levels. Since thyroid antibodies are competitive assays, they show false increases, creating the characteristic pattern resembling Graves disease. Different platforms show varying susceptibility: Roche has 81 susceptible assays, Siemens 21, Beckman 15.

Sandwich ELISA captures antigens between two antibody layers: capture antibodies coat wells, antigens bind, then enzyme-conjugated detection antibodies bind to different epitopes, forming a sandwich structure around the antigen. Competitive ELISA measures antigen concentration by competing with coated antigen for antibody binding sites; samples with more antigen produce less color because fewer free antibodies remain to bind enzyme-conjugated antibodies. These methods serve different diagnostic purposes based on whether detecting antibodies or quantifying antigens is required.

Direct immunoassays immobilize target antigen and detect using labeled antibody in single step. Sandwich immunoassays use two antibodies: capture antibody immobilized on surface binds target, and detection antibody binds another epitope, providing signal amplification through multiple binding events. Competitive immunoassays involve labeled tracer molecules competing with unlabeled target analytes for binding sites—maximum tracer binding occurs at zero analyte concentration, decreasing as target concentration increases. Each format suits different analytical needs: direct assays are simple, sandwich assays offer higher sensitivity, and competitive assays are ideal for small molecule analytes.

Immunoassays detect analytes using antibodies. In sandwich immunoassay, capture antibody binds antigen to a surface, and signal antibody with label binds to a different epitope, producing signal proportional to antigen concentration. In competitive immunoassay, limited capture antibody sites compete between unlabeled analyte and labeled antigen-conjugate; higher analyte concentration displaces more labeled antigen, producing lower signal. These principles underlie ELISA (enzyme-linked immunosorbent assay) and other immunoassays used for diagnostic testing.